Literature DB >> 15383491

Haplotype structure and allele frequencies of CYP2B6 in a Korean population.

Joo-Youn Cho1, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin, In-Jin Jang.   

Abstract

Cytochrome P450 2B6 (CYP2B6) metabolizes a number of therapeutic drugs and its metabolic activity varies markedly in human liver. Although genetic polymorphisms of CYP2B6 have been reported in noncoding and coding regions, little information is available regarding single nucleotide polymorphisms (SNPs) and their haplotypes in noncoding regions in Asians. Fourteen previously reported SNPs were determined by polymerase chain reaction-restriction fragment length polymorphism or SNaPshot analysis in a Korean population and their haplotypes were inferred from genotype data using an expectation-maximization algorithm. The most common haplotypes were haplotype I, the reference sequence (frequency 0.35), haplotype II (0.19), haplotype III (0.19), and haplotype V (0.12), which together accounted for 85% of all haplotypes. The frequency of haplotype III, which contains -2320C, -1778G, -1186G, -750C, and 15582T, was found to be 2.4-fold higher than that of the *1J allele in Caucasians, and the frequency of haplotype V, which contains -8207C, -1456C, -750C, 516T, and 785G, was 55% of that of the *6B allele in Caucasians. Moreover, haplotype V, the *6B allele, appeared to be completely linked to -8207 within a putative nuclear receptor binding motif, suggesting that lower expressions of the *6B allele may be associated with the presence of noncoding SNPs such as -8207G>C linked to nonsynonymous SNPs. In conclusion, we found 11 previously described polymorphisms and identified four major haplotypes of CYP2B6 in Koreans. The frequencies of the *1J or *6B alleles, which may reduce CYP2B6 enzyme expression, were found to be significantly different between Koreans and Caucasians.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383491     DOI: 10.1124/dmd.104.001107

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  23 in total

1.  Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea.

Authors:  Rajeev K Mehlotra; Mark N Ziats; Moses J Bockarie; Peter A Zimmerman
Journal:  Eur J Clin Pharmacol       Date:  2006-02-28       Impact factor: 2.953

2.  Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index.

Authors:  Fen Jiang; Zeruesenay Desta; Ji-Hong Shon; Chang-Woo Yeo; Ho-Sook Kim; Kwang-Hyeon Liu; Soo-Kyung Bae; Sang-Seop Lee; David A Flockhart; Jae-Gook Shin
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

3.  Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese.

Authors:  Su Guan; Min Huang; Xin Li; Xiao Chen; Eli Chan; Shu-Feng Zhou
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

4.  Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.

Authors:  Corie A Ellison; Soheir S Abou El-Ella; Maha Tawfik; Pamela J Lein; James R Olson
Journal:  J Toxicol Environ Health A       Date:  2012

Review 5.  Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.

Authors:  Rajeev K Mehlotra; Cara N Henry-Halldin; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

6.  Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes.

Authors:  Numan Oezguen; Santosh Kumar; Aditya Hindupur; Werner Braun; B K Muralidhara; James R Halpert
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

7.  CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.

Authors:  Geetha Ramachandran; A K Hemanth Kumar; Sikhamani Rajasekaran; P Kumar; K Ramesh; S Anitha; G Narendran; Pradeep Menon; C Gomathi; Soumya Swaminathan
Journal:  Antimicrob Agents Chemother       Date:  2009-01-05       Impact factor: 5.191

8.  Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

Authors:  M I Veiga; S Asimus; P E Ferreira; J P Martins; I Cavaco; V Ribeiro; T N Hai; M G Petzold; A Björkman; M Ashton; J P Gil
Journal:  Eur J Clin Pharmacol       Date:  2008-11-01       Impact factor: 2.953

9.  Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.

Authors:  Lan Fan; Jin-Chao Wang; Feng Jiang; Zhi-Rong Tan; Yao Chen; Qing Li; Wei Zhang; Guo Wang; He-Ping Lei; Dong-Li Hu; Dan Wang; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2008-12-09       Impact factor: 2.953

10.  Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.

Authors:  Nazan Yuce-Artun; Bora Baskak; Erguvan Tugba Ozel-Kizil; Hatice Ozdemir; Zuhal Uckun; Halise Devrimci-Ozguven; Halit Sinan Suzen
Journal:  Int J Clin Pharm       Date:  2016-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.